Revanesse Shape+ (w/Lidocaine) 2x1.2ml
Revanesse® Shape™ is a viscosity HA gel optimized with Thixofix® cross-linking technology for medium to deep facial rhytides. As a smooth and very viscous gel, Shape™ is ideal for correcting very deep tissue areas within the supra-periosteal plane to shape and volumize.
Revanesse® Shape™, manufactured by Prollenium Medical Technologies Inc, have a very high elasticity (G’) provides stiffness (lift capacity) for projection, while a high yield stress (higher shape retention or higher amount of force required to deform the gel) and optimal cohesivity (adhesive strength) provide maximum shape retention needed for the dynamic forces and movements of the face. HA dermal fillers with equivalent (high) G’, high yield stress and high (optimal) cohesivity provide the necessary attributes for integration into the supra-periosteal plane for projection and lift.
Revanesse® HA particles are round and smooth. Inflammatory reactions are more pronounced for particles of irregular shape.
IN VITRO STUDY SIMULATING VASCULAR OCCLUSION
In case of an emergency, Revanesse® Shape™ breaks down quickly and uniformly with hyaluronidase.
UNIFORMITY AND CONSISTENCY
Consistency in shape and texture enables Shape™ to flow smoothly from the syringe despite being highly viscous and having a large average particle size.
High molecular weight HA for minimizing the inflammatory response
Optimal cohesivity for adapting to the surrounding tissue and injection depth
Smooth & uniform injection for accuracy and precision
High yield stress for maximum shape retention in very deep tissue areas
High elasticity (G’) for stiffness (lift capacity)
Revanesse® Shape™ displays a very high stiffness (G’) for projection and lift, a high yield stress for maximum shape retention, and an optimized cohesivity for adapting to the surrounding tissue and injection depth.
WHY SHAPE ™?
1. Ideal physicochemical properties for stiffness (lift capacity) and shape retention
2. Optimal integration into the periosteum
3. Designed for safety with round and smooth HA particles
HA 25 mg/ml, Lidocaine 0,3%
up to 18 months
Thixofix cross-linking technology
2 syringes х 1.2 ml
The product isn't intended for personal use due to certain restrictions, and should only be administered by a trained medical specialist.
Prollenium Medical Technologies
Country of origin